Which contraceptive side effects matter most? Evidence from current and past users of injectables and implants in Western Kenya

Q2 Medicine Contraception: X Pub Date : 2020-01-01 DOI:10.1016/j.conx.2020.100030
George Odwe , Francis Obare , Kazuyo Machiyama , John Cleland
{"title":"Which contraceptive side effects matter most? Evidence from current and past users of injectables and implants in Western Kenya","authors":"George Odwe ,&nbsp;Francis Obare ,&nbsp;Kazuyo Machiyama ,&nbsp;John Cleland","doi":"10.1016/j.conx.2020.100030","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The objectives were to assess experiences of menstrual bleeding and nonbleeding side effects among current and past users of injectables and implants and the associations between side effects and method evaluations by women — satisfaction, perceived suitability, the likelihood of future use and intended duration of use.</p></div><div><h3>Study design</h3><p>We used data on past and current users of injectables and implants from a survey of 1866 married or cohabiting women who participated in the third round of a 2-year prospective longitudinal study conducted in Homa Bay County, Western Kenya. Descriptive and bivariate analysis with <em>χ<sup>2</sup></em> tests was used to assess statistically significant associations between experience of bleeding/nonbleeding side effects and method-specific attitudes.</p></div><div><h3>Results</h3><p>Self-reported method-related bleeding problems were high among current and past users of injectables (range 69%–79%) and implants (range 55%–60%) and much more common than nonbleeding side effects. For both methods, experience of either bleeding or nonbleeding side effects reduces positive evaluations, but the conjunction of both types had particularly pronounced consequences. Heavy bleeding was more strongly related to method evaluation (satisfaction and the likelihood of future use; p &lt; .001) among past users than other forms of menstrual bleeding disorders. Even among current users, about one third regarded bleeding side effects as very serious. Care-seeking from a healthcare provider for management of contraceptive-related side effects was low among current users (less than 40%) and modest among past users (range 53%–63%).</p></div><div><h3>Conclusions</h3><p>The results underscore the need to strengthen programs on counseling and information on contraceptive side effects including menstrual bleeding disturbances to improve method satisfaction and reduce discontinuation.</p></div><div><h3>Implication</h3><p>The experience of contraceptive-related menstrual bleeding and nonbleeding side effects reduces positive evaluation of the method and deters past users from future use of the method.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"2 ","pages":"Article 100030"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.conx.2020.100030","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590151620300137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5

Abstract

Objectives

The objectives were to assess experiences of menstrual bleeding and nonbleeding side effects among current and past users of injectables and implants and the associations between side effects and method evaluations by women — satisfaction, perceived suitability, the likelihood of future use and intended duration of use.

Study design

We used data on past and current users of injectables and implants from a survey of 1866 married or cohabiting women who participated in the third round of a 2-year prospective longitudinal study conducted in Homa Bay County, Western Kenya. Descriptive and bivariate analysis with χ2 tests was used to assess statistically significant associations between experience of bleeding/nonbleeding side effects and method-specific attitudes.

Results

Self-reported method-related bleeding problems were high among current and past users of injectables (range 69%–79%) and implants (range 55%–60%) and much more common than nonbleeding side effects. For both methods, experience of either bleeding or nonbleeding side effects reduces positive evaluations, but the conjunction of both types had particularly pronounced consequences. Heavy bleeding was more strongly related to method evaluation (satisfaction and the likelihood of future use; p < .001) among past users than other forms of menstrual bleeding disorders. Even among current users, about one third regarded bleeding side effects as very serious. Care-seeking from a healthcare provider for management of contraceptive-related side effects was low among current users (less than 40%) and modest among past users (range 53%–63%).

Conclusions

The results underscore the need to strengthen programs on counseling and information on contraceptive side effects including menstrual bleeding disturbances to improve method satisfaction and reduce discontinuation.

Implication

The experience of contraceptive-related menstrual bleeding and nonbleeding side effects reduces positive evaluation of the method and deters past users from future use of the method.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
哪种避孕药的副作用最严重?来自肯尼亚西部目前和过去注射和植入物使用者的证据
目的:评估目前和过去使用注射剂和植入物的患者的月经出血和非出血副作用的经历,以及副作用与女性评估方法之间的关系——满意度、感知的适用性、未来使用的可能性和预期使用时间。研究设计:我们使用了来自1866名已婚或同居妇女的数据,这些妇女参加了在肯尼亚西部Homa Bay县进行的为期2年的前瞻性纵向研究的第三轮调查。描述性和双变量分析采用χ2检验来评估出血/非出血副作用经历与方法特异性态度之间的统计学显著相关性。结果目前和过去使用注射剂(69%-79%)和植入物(55%-60%)的患者中,自我报告的与方法相关的出血问题很高,比非出血副作用更常见。对于这两种方法,出血或不出血副作用的经历都会降低积极的评价,但两种类型的结合会产生特别明显的后果。大出血与方法评价(满意度和未来使用的可能性)的相关性更强;P < .001)比其他形式的月经出血障碍。即使在目前的使用者中,大约三分之一的人认为出血副作用非常严重。目前使用者为避孕相关副作用向卫生保健提供者求诊的比例较低(不到40%),过去使用者的比例较低(53%-63%)。结论需要加强对包括月经紊乱在内的避孕副作用的咨询和宣传,以提高避孕方法的满意度,减少停药。与避孕药相关的月经出血和非出血性副作用的经历降低了对该方法的积极评价,并阻止过去的使用者今后使用该方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Contraception: X
Contraception: X Medicine-Obstetrics and Gynecology
CiteScore
5.10
自引率
0.00%
发文量
17
审稿时长
22 weeks
期刊最新文献
Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series Experiences of delay-causing obstacles and mental health at the time of abortion seeking Maximizing the effectiveness of 1.5 mg levonorgestrel for emergency contraception: The case for precoital use How does person-centered maternity care relate to postpartum contraceptive counseling and use? Evidence from a longitudinal study of women delivering at health facilities in Ethiopia Dilation and evacuation versus medication abortion at 15–24 weeks of gestation in low-middle income country: A retrospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1